Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Comparison of Glycemic Control Achieved With 2 Different Needles [Phase 4]
Phase 4 clinical trial comparing glycemic control achieved with two different insulin needles; sponsored by Novo Nordisk A/S, the study is c…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India
This completed clinical trial survey, sponsored by Novo Nordisk in India, evaluated diabetes management, control, chronic complications, and…
-
CLINICAL_TRIALS research · 2017-01-19Clinical Trial Update: Diabetes Attitudes Wishes and Needs
Clinical trial update for the Diabetes Attitudes Wishes and Needs survey (NCT01507116) sponsored by Novo Nordisk; the study status is comple…
-
CLINICAL_TRIALS other · 2017-01-19Clinical Trial Update: Evaluating the Use of Two Different Needles in Subjects With Diabetes [Phase 4]
Clinical trial update describing a Phase 4 study comparing two different needle designs in subjects with diabetes; the study status is compl…
-
FDA approval · 2017-01-18FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) to introduce its extended-release formulati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-01-18FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Januvia (sitagliptin) submitted by Merck Sharp & Dohme LLC. The snippet does not specify the…
-
FDA approval · 2017-01-18FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin/metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes [Phase 1]
A Phase 1 trial of NN1218 in subjects with Type 1 and Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 Diabetes [NA]
A completed clinical trial studied how breakfast composition affects glycemic and incretin responses in individuals with type 2 diabetes, wi…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Neck Grasp as a Predictor of Sleep Apnea [NA]
Completed clinical trial evaluating neck grasp as a predictor of obstructive sleep apnea, including participants with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies [Phase 2, Phase 3]
This clinical trial update reports the completion of Phase 2 and Phase 3 studies assessing insulin sensitivity and beta cell function using …
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Study of the Potential of a Macronutrient Balanced Normocaloric Diet to Treat Lifestyle Diseases [NA]
A completed clinical trial from the Norwegian University of Science and Technology evaluated a macronutrient-balanced normocaloric diet for …
-
CLINICAL_TRIALS research · 2017-01-13Clinical Trial Update: GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
This clinical trial update reports on the GAPP 2 survey evaluating global attitudes of patients and physicians toward insulin therapy in ind…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese [Phase 4]
Phase 4 clinical trial evaluating a GLP-1 receptor agonist plus metformin for diabetes remission in overweight or obese adults newly diagnos…
-
FDA approval · 2017-01-11FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
FDA approved a supplemental application for glyburide from Teva Pharmaceuticals USA Inc, resulting in changes to the labeling.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing Biphasic Insulin Aspart 70/30 to Insulin Glargine in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing Biphasic Insulin Aspart 70/30 with other anti-diabetic drugs in adults with Type 2 diabetes; the study has completed…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes [Phase 4]
Phase 4 trial assessing the efficacy and safety of Biphasic Insulin Aspart 30 in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009) [Phase 2]
Phase 2 study of MK-3577 in type 2 diabetes mellitus was terminated with posted results in 2017.
-
CLINICAL_TRIALS research · 2017-01-11Clinical Trial Update: Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus.
Clinical trial update examining coronary artery plaque burden and morphology in individuals with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin
This document provides an update on an observational safety study evaluating NovoMix in adults with Type 2 diabetes who were previously trea…
-
FDA approval · 2017-01-10FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a dapagliflozin and metformin hydrochloride combination product, manufactured by Prasco Laborato…
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Association Between Glycaemic Control and Morbi/Mortality After 5 Years of Follow-up in Type 2 Diabetic Patients
Clinical trial update examining how glycemic control influences morbidity and mortality after five years in people with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes [Phase 3]
Phase 3 trial evaluating hepatic dysfunction and vitamin D status in people with type 2 diabetes mellitus and nonalcoholic fatty liver disea…
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.
Takeda-sponsored cohort study assessed cancer incidence among people with type 2 diabetes treated with pioglitazone; results were posted in …